NCT01701674 2025-12-19Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets PtsH. Lee Moffitt Cancer Center and Research InstitutePhase NA Completed13 enrolled 10 charts